Cargando…
Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor
The majority of cancer-related deaths are caused by tumor recurrence, metastasis and therapeutic resistance. During the late stages of tumor progression, multiple factors are involved, including the downregulation and/or loss of function of metastasis suppressors. Epithelial protein lost in neoplasm...
Autor principal: | Wu, Daqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136588/ https://www.ncbi.nlm.nih.gov/pubmed/30258911 http://dx.doi.org/10.1016/j.gendis.2017.03.002 |
Ejemplares similares
-
Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers
por: Zeng, Jianyuan, et al.
Publicado: (2021) -
Epithelial Protein Lost in Neoplasm α (Eplin-α) is transcriptionally regulated by G-actin and MAL/MRTF coactivators
por: Leitner, Laura, et al.
Publicado: (2010) -
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
por: Zeng, Jianyuan, et al.
Publicado: (2022) -
LUZP1 and the tumor suppressor EPLIN modulate actin stability to restrict primary cilia formation
por: Gonçalves, João, et al.
Publicado: (2020) -
Mechanosensitive EPLIN-dependent remodeling of adherens junctions regulates epithelial reshaping
por: Taguchi, Katsutoshi, et al.
Publicado: (2011)